These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
993 related articles for article (PubMed ID: 29143812)
21. NLRP3 inflammasome: A likely target for the treatment of allergic diseases. Xiao Y; Xu W; Su W Clin Exp Allergy; 2018 Sep; 48(9):1080-1091. PubMed ID: 29900602 [TBL] [Abstract][Full Text] [Related]
22. P2X Yin J; Wang Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Yang N; Shi Y; Yan S J Cell Mol Med; 2017 Nov; 21(11):2695-2710. PubMed ID: 28470940 [TBL] [Abstract][Full Text] [Related]
23. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606 [TBL] [Abstract][Full Text] [Related]
24. Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction. Silvis MJM; Demkes EJ; Fiolet ATL; Dekker M; Bosch L; van Hout GPJ; Timmers L; de Kleijn DPV J Cardiovasc Transl Res; 2021 Feb; 14(1):23-34. PubMed ID: 32648087 [TBL] [Abstract][Full Text] [Related]
25. The NLRP3 inflammasome in kidney disease and autoimmunity. Hutton HL; Ooi JD; Holdsworth SR; Kitching AR Nephrology (Carlton); 2016 Sep; 21(9):736-44. PubMed ID: 27011059 [TBL] [Abstract][Full Text] [Related]
26. Regulation and functions of NLRP3 inflammasome in cardiac fibrosis: Current knowledge and clinical significance. Zhang X; Qu H; Yang T; Kong X; Zhou H Biomed Pharmacother; 2021 Nov; 143():112219. PubMed ID: 34560540 [TBL] [Abstract][Full Text] [Related]
27. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase. Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434 [TBL] [Abstract][Full Text] [Related]
28. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. Martínez GJ; Celermajer DS; Patel S Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570 [TBL] [Abstract][Full Text] [Related]
29. Methylsulfonylmethane inhibits NLRP3 inflammasome activation. Ahn H; Kim J; Lee MJ; Kim YJ; Cho YW; Lee GS Cytokine; 2015 Feb; 71(2):223-31. PubMed ID: 25461402 [TBL] [Abstract][Full Text] [Related]
30. NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis Model. Gugliandolo A; Giacoppo S; Bramanti P; Mazzon E Inflammation; 2018 Feb; 41(1):93-103. PubMed ID: 28936769 [TBL] [Abstract][Full Text] [Related]
31. NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction. Lei Q; Yi T; Chen C Med Sci Monit; 2018 Aug; 24():6044-6052. PubMed ID: 30161099 [TBL] [Abstract][Full Text] [Related]
32. Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression. Li R; Lu K; Wang Y; Chen M; Zhang F; Shen H; Yao D; Gong K; Zhang Z Biochem Biophys Res Commun; 2017 Mar; 485(1):69-75. PubMed ID: 28202417 [TBL] [Abstract][Full Text] [Related]
33. The selective Nlrp3 inflammasome inhibitor Mcc950 attenuates lung ischemia-reperfusion injury. Xu KY; Wu CY; Tong S; Xiong P; Wang SH Biochem Biophys Res Commun; 2018 Sep; 503(4):3031-3037. PubMed ID: 30146255 [TBL] [Abstract][Full Text] [Related]
34. The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis. Alyaseer AAA; de Lima MHS; Braga TT Front Immunol; 2020; 11():883. PubMed ID: 32508821 [TBL] [Abstract][Full Text] [Related]
35. NLRP3 inflammasome in ischemic stroke: As possible therapeutic target. Alishahi M; Farzaneh M; Ghaedrahmati F; Nejabatdoust A; Sarkaki A; Khoshnam SE Int J Stroke; 2019 Aug; 14(6):574-591. PubMed ID: 30940045 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway. Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354 [TBL] [Abstract][Full Text] [Related]
37. Exogenous nanoparticles and endogenous crystalline molecules as danger signals for the NLRP3 inflammasomes. Shirasuna K; Karasawa T; Takahashi M J Cell Physiol; 2019 May; 234(5):5436-5450. PubMed ID: 30370619 [TBL] [Abstract][Full Text] [Related]
38. Inhibitors of NLRP3 Inflammasome Formation: A Cardioprotective Role for the Gasotransmitters Carbon Monoxide, Nitric Oxide, and Hydrogen Sulphide in Acute Myocardial Infarction. Payne FM; Dabb AR; Harrison JC; Sammut IA Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273196 [TBL] [Abstract][Full Text] [Related]
39. Activation of Nrf2 pathway and inhibition of NLRP3 inflammasome activation contribute to the protective effect of chlorogenic acid on acute liver injury. Shi A; Shi H; Wang Y; Liu X; Cheng Y; Li H; Zhao H; Wang S; Dong L Int Immunopharmacol; 2018 Jan; 54():125-130. PubMed ID: 29128856 [TBL] [Abstract][Full Text] [Related]
40. Activation in M1 but not M2 Macrophages Contributes to Cardiac Remodeling after Myocardial Infarction in Rats: a Critical Role of the Calcium Sensing Receptor/NRLP3 Inflammasome. Liu W; Zhang X; Zhao M; Zhang X; Chi J; Liu Y; Lin F; Fu Y; Ma D; Yin X Cell Physiol Biochem; 2015; 35(6):2483-500. PubMed ID: 25967877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]